Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of HRMY will decline by -22.22% over the next 2 Weeks and hit $22.04 by Friday, March 20, 2026. In that time frame, HRMY's share price is expected to range between $20.39 and $23.74.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 20, 2026 | 20.24 | 22.04 | 23.83 |
| Mar 19, 2026 | 21.29 | 23.05 | 24.84 |
| Mar 18, 2026 | 21.67 | 23.49 | 25.17 |
| Mar 17, 2026 | 22.60 | 24.27 | 25.91 |
| Mar 16, 2026 | 22.33 | 24.03 | 25.64 |
| Mar 13, 2026 | 23.47 | 25.18 | 26.80 |
| Mar 12, 2026 | 24.43 | 26.19 | 27.79 |
| Mar 11, 2026 | 24.91 | 26.64 | 28.35 |
| Mar 10, 2026 | 25.84 | 27.41 | 29.10 |
| Mar 9, 2026 | 25.57 | 27.18 | 28.89 |
HRMY shares rose +0.85% in Monday, March 9, 2026's trading session, rising from a previous close of $28.33 to move at $28.57. The stock demonstrated notable intraday movement (see HRMY's key stats for a full breakdown), fluctuating between $27.39 and $28.63, a +4.53% trading range. While recent weeks have seen some volatility, HRMY has managed to secure a -2.02% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 696.27K shares changing hands, 28.57K fewer than the previous session. This amounted to $19.89M in total market activity.
Will HRMY Continue Its Downward Trend?
According to analyst ratings and projections for HRMY, Harmony Biosciences Holdings, Inc. shares are anticipated to decrease by -19.89%, potentially reaching $23.83 per share by March 20, 2026. Short-term technical indicators for HRMY currently suggest a bearish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the HRMY stock forecast, now is not the best time to buy HRMY stock because its current trading price is +29.65% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on HRMY covering social and institutional perspectives.
HRMY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into HRMY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 32.96% to 34.57%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 41.65%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.68%, maintains a neutral outlook for the long term. Insights into HRMY's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Harmony Biosciences Short-Term Forecasts
HRMY Forecast For Next 5 Days
Our algorithm anticipates Harmony Biosciences (HRMY) stock could hit $25.13 by Mar 16, 2026. This represents a -12.03% fall from today's price, following a -6.17% change over the past five days.
HRMY Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Harmony Biosciences Holdings, Inc. (HRMY) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $23.71, which would mean a -17.01% decrease from the current price of $28.57. Projections for this period range from a high of $30.17 to a low of $18.00.
HRMY Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Harmony Biosciences's price over the next three months point to a rise. HRMY stock is expected to peak at $33.77 on May 14, 2026 after potentially dipping to $25.43 on Mar 16, 2026. On average, HRMY is likely to trade around $29.83 in the coming 90 days.
Harmony Biosciences Stock Forecast 2025
Based on our predictive models, Harmony Biosciences (HRMY) is expected to trade between $23.66 and $33.77 throughout 2026. This would result in an average price of $29.01, potentially offering investors a +1.54% return from current levels.
Harmony Biosciences Holdings, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Harmony Biosciences Holdings, Inc. (HRMY) is positioned to show a strong performance in March 2026. The price is predicted to move between $25.43 and $30.14, settling at an average of $27.83. This could translate to a -2.59% loss.
April 2026
Based on current market signals, Harmony Biosciences Holdings, Inc. is projected to trend april 2026. We forecast a trading range from $26.90 to $32.49, with a likely average price of $29.85. Investors could expect a potential return of +4.48%.
May 2026
Our predictive algorithms indicate Harmony Biosciences Holdings, Inc. stock may see a shift in May 2026. The expected range spans $28.52–$33.77, with an average target of $31.24. This represents a positive outlook and a possible gain of +9.35%.
June 2026
Analyzing established trends, Harmony Biosciences Holdings, Inc. looks set to move in June 2026. Projections place the stock between $27.07 and $32.95, averaging around $30.08. This suggests a +5.29% gain from current levels.
July 2026
Market indicators suggest Harmony Biosciences Holdings, Inc. could experience notable changes during July 2026. Prices could fluctuate within $24.23 to $31.26, with a midpoint forecast of $27.49. The stock might deliver a -3.78% loss.
August 2026
Forecasting for August 2026, models estimate that Harmony Biosciences Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $24.69 and $30.17, averaging $27.37. This signals a cautious trajectory with potential returns around -4.20%.
September 2026
According to our latest forecast models, Harmony Biosciences Holdings, Inc. (HRMY) is positioned to show a strong performance in September 2026. The price is predicted to move between $26.95 and $32.08, settling at an average of $29.45. This could translate to a +3.08% gain.
October 2026
Based on current market signals, Harmony Biosciences Holdings, Inc. is projected to trend october 2026. We forecast a trading range from $27.02 to $33.37, with a likely average price of $30.51. Investors could expect a potential return of +6.79%.
November 2026
Our predictive algorithms indicate Harmony Biosciences Holdings, Inc. stock may see a shift in November 2026. The expected range spans $26.27–$32.98, with an average target of $29.44. This represents a positive outlook and a possible gain of +3.05%.
December 2026
Analyzing established trends, Harmony Biosciences Holdings, Inc. looks set to move in December 2026. Projections place the stock between $23.66 and $30.26, averaging around $26.80. This suggests a -6.20% loss from current levels.
January 2027
Market indicators suggest Harmony Biosciences Holdings, Inc. could experience notable changes during January 2027. Prices could fluctuate within $24.07 to $29.92, with a midpoint forecast of $26.88. The stock might deliver a -5.92% loss.
February 2027
Forecasting for February 2027, models estimate that Harmony Biosciences Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $26.51 and $31.23, averaging $28.89. This signals a positive trajectory with potential returns around +1.12%.
March 2027
According to our latest forecast models, Harmony Biosciences Holdings, Inc. (HRMY) is positioned to show a strong performance in March 2027. The price is predicted to move between $28.03 and $32.71, settling at an average of $30.51. This could translate to a +6.79% gain.
HRMY's history of dividends and stock splits also plays a role in long-term investor confidence.

